- Home
- BGLC vs KAVL Comparison
BGLC vs KAVL Comparison
Compare BGLC & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- KAVL
- Stock Information
- Founded
- BGLC 2017
- KAVL 1998
- Country
- BGLC Malaysia
- KAVL United States
- Employees
- BGLC N/A
- KAVL N/A
- Industry
- BGLC Medical Specialities
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- BGLC Health Care
- KAVL Health Care
- Exchange
- BGLC Nasdaq
- KAVL Nasdaq
- Market Cap
- BGLC 10.4M
- KAVL 9.6M
- IPO Year
- BGLC N/A
- KAVL N/A
- Fundamental
- Price
- BGLC $5.66
- KAVL $0.92
- Analyst Decision
- BGLC
- KAVL
- Analyst Count
- BGLC 0
- KAVL 0
- Target Price
- BGLC N/A
- KAVL N/A
- AVG Volume (30 Days)
- BGLC 53.1K
- KAVL 6.5M
- Earning Date
- BGLC 08-18-2025
- KAVL 09-19-2025
- Dividend Yield
- BGLC N/A
- KAVL N/A
- EPS Growth
- BGLC N/A
- KAVL N/A
- EPS
- BGLC N/A
- KAVL N/A
- Revenue
- BGLC $9,551,559.00
- KAVL $1,698,426.00
- Revenue This Year
- BGLC N/A
- KAVL N/A
- Revenue Next Year
- BGLC N/A
- KAVL N/A
- P/E Ratio
- BGLC N/A
- KAVL N/A
- Revenue Growth
- BGLC 4.01
- KAVL N/A
- 52 Week Low
- BGLC $2.01
- KAVL $0.45
- 52 Week High
- BGLC $15.60
- KAVL $1.95
- Technical
- Relative Strength Index (RSI)
- BGLC 52.45
- KAVL 59.39
- Support Level
- BGLC $5.45
- KAVL $0.78
- Resistance Level
- BGLC $5.81
- KAVL $1.16
- Average True Range (ATR)
- BGLC 0.20
- KAVL 0.15
- MACD
- BGLC -0.02
- KAVL 0.01
- Stochastic Oscillator
- BGLC 77.94
- KAVL 56.28
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.